These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6254588)

  • 41. Residual bound Ca2+ can account for the effects of Ca2+ buffers on synaptic facilitation.
    Matveev V; Bertram R; Sherman A
    J Neurophysiol; 2006 Dec; 96(6):3389-97. PubMed ID: 16971687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice.
    Illes P; Schulz R
    Br J Pharmacol; 1980; 71(1):195-200. PubMed ID: 6258687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On facilitation of transmitter release at the toad neuromuscular junction.
    Balnave RJ; Gage PW
    J Physiol; 1974 Jun; 239(3):657-75. PubMed ID: 4152979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crayfish neuromuscular facilitation activated by constant presynaptic action potentials and depolarizing pulses.
    Zucker RS
    J Physiol; 1974 Aug; 241(1):69-89. PubMed ID: 4153766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paired-pulse facilitation of transmitter release at different levels of extracellular calcium concentration.
    Mukhamedyarov MA; Zefirov AL; Palotás A
    Neurochem Res; 2006 Aug; 31(8):1055-8. PubMed ID: 16871441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do alpha 2-agonists inhibit sympathetic transmitter secretion in part by depressing a Ca2+ component of the nerve impulse 'upstream' of varicosities?
    Stjärne C; Stjärne E; Msghina M
    Acta Physiol Scand; 1988 Aug; 133(4):591-2. PubMed ID: 2906514
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of morphine on the release of noradrenaline from the mouse vas deferens.
    Henderson G; Hughes J
    Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vecuronium suppresses transmission at the rat phrenic neuromuscular junction by inhibiting presynaptic L-type calcium channels.
    Ji F; Han J; Liu B; Wang H; Shen G; Tao J
    Neurosci Lett; 2013 Jan; 533():1-6. PubMed ID: 23200725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An analysis of the role of calcium in facilitation at the frog neuromuscular junction.
    Younkin SG
    J Physiol; 1974 Feb; 237(1):1-14. PubMed ID: 4545024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).
    Al-Kazwini SJ; Craig RK; Marshall I
    Br J Pharmacol; 1986 May; 88(1):173-80. PubMed ID: 3486688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.
    Henderson G; Hughes J; Kosterlitz HW
    Br J Pharmacol; 1972 Dec; 46(4):764-6. PubMed ID: 4655272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R; Barrett EF
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of transmitter release by strontium and calcium ions at the neuromuscular junction.
    Meiri U; Rahamimoff R
    J Physiol; 1971 Jul; 215(3):709-26. PubMed ID: 4326307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chronic clonidine treatment on transmitter release from sympathetic varicosities of the guinea-pig vas deferens.
    Knight D; Cunnane TC; Lavidis NA
    Br J Pharmacol; 2001 Dec; 134(7):1480-6. PubMed ID: 11724754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single Ca2+ entry and transmitter release systems at the neuromuscular synapse.
    Guan YY; Quastel DM; Saint DA
    Synapse; 1988; 2(5):558-64. PubMed ID: 2847344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
    Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
    Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential cotransmission in sympathetic nerves: role of frequency of stimulation and prejunctional autoreceptors.
    Todorov LD; Mihaylova-Todorova ST; Bjur RA; Westfall DP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):241-6. PubMed ID: 10381782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphine and nalorphine impair neuromuscular transmission.
    Pinsky C; Frederickson RC
    Nat New Biol; 1971 May; 231(20):94-6. PubMed ID: 4325657
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea-pig vas deferens.
    Ellis JL; Burnstock G
    Br J Pharmacol; 1990 Jul; 100(3):457-62. PubMed ID: 2167733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.